A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...

Outbounder ARS in Mason has introduced a new virtual reality therapy that uses an exercise machine to aid in the ...

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

India's Supernova stent retriever, approved for severe stroke treatment, launches in February 2026, promising affordable ...

Big Brother season 27 star Mickey Lee was hospitalized after a "series of cardiac arrests," according to a GoFundMe page set ...

THE HSE have issued an urgent Christmas alert over a “life-threatening condition” that impacts 1 in 4 – here’s the warning ...

The prosecution called medical doctors to the stand on Wednesday in the Charles Teeple trial, confirming from the autopsy that the cause of death, as a homicide, was ...

Investing.com -- A patient died after receiving Pfizer Inc.’s (NYSE:PFE) hemophilia drug Hympavzi, adding to challenges for the company in blood disorder treatments.

The defense began Thursday’s proceedings by calling Dr. Donoghue, the coroner, back to the stand. Dr. Donoghue had previously testified on Wednesday in the ...

Health Canada recently approved the injection treatment for acute ischemic stroke in adults, the first stroke medicine ...